An Easy and Rapid Spectrophotometric Method for Determination of Chloroquine Diphosphate in Tablets

(E-pub Ahead of Print)

Author(s): Mateus Araujo Castro e Souza*, Naialy Fernandes Araujo Reis, Larissa de Souza Batista, Isabela da Costa Cesar, Christian Fernandes, Gerson Antonio Pianetti.

Journal Name: Current Pharmaceutical Analysis

Submit Manuscript
Submit Proposal


Malaria, an infectious disease caused by protozoa of the genus Plasmodium, is highly prevalent in the Brazilian Amazon. Chloroquine is the first-choice drug for the treatment of malaria caused by P. vivax and P. malariae. The humid and hot climate characteristic of the Brazilian endemic region favors drug degradation and modification of its biopharmaceutical properties, which may result in subtherapeutic dosage, formation of degradation products that can be toxic to humans and appearance of parasitic resistance. Thus, it is necessary to monitor the quality of chloroquine tablets. For this purpose, an analytical method was developed and validated to determine chloroquine content in tablets by ultraviolet spectrophotometry. The diluent consisted of 0.06 M monosodium phosphate buffer pH 6.8 and detection was performed at 343 nm. The method proved to be linear in the range of 7.2 to 19.2 µg mL-1, precise, accurate, selective, robust, and statistically equivalent to a liquid chromatographic method by the United States Pharmacopeia. The developed method was applied to determine chloroquine content in six batches of the drug. The evaluated batches were considered adequate for identification, assay, dissolution, disintegration and uniformity of dosage units, and were found to be inadequate in terms of friability.

Keywords: Malaria, chloroquine diphosphate, tablets, ultraviolet spectrophotometry, analytical method development, quality control

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1573412914666180730123426
Price: $95